Cargando…
Preclinical studies of N(3)-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H(22)-bearing mice
PURPOSE: N(3)-O-toluyl-fluorouracil (TFU) is a potential antitumor prodrug of 5-fluorouracil (5-FU), but its poor solubility has limited its use in clinic. This study aimed to improve the bioavailability of TFU by preparing TFU-loaded lipid-based nanosuspensions (TFU-LNS) and perform a preclinical e...
Autores principales: | Zhang, Juan, Li, Min, Liu, Zhihong, Wang, Lili, Liu, Yongjun, Zhang, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045086/ https://www.ncbi.nlm.nih.gov/pubmed/24920908 http://dx.doi.org/10.2147/IJN.S59338 |
Ejemplares similares
-
N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU
por: Zhang, Xiaofan, et al.
Publicado: (2009) -
In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer
por: Yang, Shaomei, et al.
Publicado: (2016) -
Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency
por: Wang, Tianqi, et al.
Publicado: (2017) -
Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo
por: Pang, Xiuping, et al.
Publicado: (2019) -
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
por: Wang, Lili, et al.
Publicado: (2012)